These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 6210587)
1. An usual presentation of fixed drug eruption. Kanwar AJ; Majid A; Singh M; Malhotra YK Dermatologica; 1982 Feb; 164(2):115-6. PubMed ID: 6210587 [No Abstract] [Full Text] [Related]
2. Independent lesions of fixed eruption due to two unrelated drugs in the same patient. Pasricha JS; Shukla SR Br J Dermatol; 1979 Sep; 101(3):361-2. PubMed ID: 159715 [No Abstract] [Full Text] [Related]
6. [Use of Dolispan in the system of managing labor]. Iarukov L; Shturkalev I; Iordanov G; Khadzhiev A Akush Ginekol (Sofiia); 1977; 16(1):8-18. PubMed ID: 324305 [No Abstract] [Full Text] [Related]
7. [Pharmacological and clinical observations on the combination of scopolamine N-butylbromide and aminopyrine sodium sulfonate (buscopan compositum)]. MARINO A; MURARO U Rass Int Clin Ter; 1959 Dec; 39():1247-93 contd. PubMed ID: 14421165 [No Abstract] [Full Text] [Related]
8. Suspected non-steroidal anti-inflammatory drug toxicity in a horse. Hunt JM; Lees P; Edwards GB Vet Rec; 1985 Nov; 117(22):581-2. PubMed ID: 4090206 [No Abstract] [Full Text] [Related]
9. [Agranulocytosis caused by foreign analgesics (Optalidon and Nolotil)]. Hopen G; Ly B; Moen T Tidsskr Nor Laegeforen; 1979 May; 99(13):635. PubMed ID: 451964 [No Abstract] [Full Text] [Related]
10. Contrast radiography of the equine oesophagus: effect of spasmolytic agents and passage of a nasogastric tube. King JN; Davies JV; Gerring EL Equine Vet J; 1990 Mar; 22(2):133-5. PubMed ID: 2318178 [No Abstract] [Full Text] [Related]
11. [Acute kidney insufficiency and hypertensive encephalopathy following administration of Baralgin]. Thien T; Huysmans FT Ned Tijdschr Geneeskd; 1988 Jan; 132(2):86-7. PubMed ID: 3340225 [No Abstract] [Full Text] [Related]
12. A fixed drug eruption to Baralgin (dipyrone) tablets. Pinto Pereira LM West Indian Med J; 1994 Dec; 43(4):146-7. PubMed ID: 7900381 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacological and clinical observations on the combination of N-butyl-bromide of hyoscine and phenyldimethyl-pyrazolone-methylamino-methanesulfonate of sodium (buscopan compositum)]. MARINO A; MURARO U Rass Int Clin Ter; 1959 Dec; 39():1333-56. PubMed ID: 14421164 [No Abstract] [Full Text] [Related]
14. Fixed drug eruption: a lesson in drug usage. Olumide Y Int J Dermatol; 1979 Dec; 18(10):818-21. PubMed ID: 160897 [TBL] [Abstract][Full Text] [Related]
15. [Use of buscopan compositum in an orthopedic and surgical practice]. DUSBERG K; REINHARD W Dtsch Med J; 1956 Nov; 7(17):662-3. PubMed ID: 13384161 [No Abstract] [Full Text] [Related]
16. Fixed drug eruptions on male genitalia: clinical and etiologic study. Pandhi RK; Kumar AS; Satish DA; Bhutani LK Sex Transm Dis; 1984; 11(3):164-6. PubMed ID: 6239399 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of Baralgan and hyoscine-N-methyl bromide in the treatment of intestinal and renal colicy pain. Benyajati C J Med Assoc Thai; 1986 Oct; 69(10):569-73. PubMed ID: 3819615 [No Abstract] [Full Text] [Related]
18. Why use Buscopan during diagnostic upper gastrointestinal endoscopy? Chopra K; Westaby D; Murray-Lyon I Gut; 1996 Mar; 38(3):473. PubMed ID: 8675106 [No Abstract] [Full Text] [Related]